Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
Patients interested in retatrutide may wish to explore participation in clinical trials
Progressive resistance exercisewhether using weights, resistance bands, or bodyweightsignals your muscles to adapt and grow, counteracting the catabolic effects of caloric deficit
This matters because visceral fat adds significantly to metabolic disease risk, even in people who arent very overweight
Some individuals on GLP-1s may consume less water and fewer foods that contain water, contributing to hydration
When Aqualyx is injected into the fatty tissue, the deoxycholic acid acts as a detergent, dissolving the cell wall and causing the cell to burst